Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Chiesi Limited
Chiesi Limited, Cheadle Royal Business Park, Highfield, Cheadle, SK8 3GY
Telephone: +44 (0) 161 488 5555
Fax: +44 (0) 161 488 5566
WWW: http://www.chiesi.uk.com
Medical Information e-mail: medinfo@chiesi.uk.com
Medical Information Fax: +44 (0) 161 488 5566

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 18/02/2011
SPC Depefex 75mg & 150mg XL Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   15-Feb-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Order of wording in the pregnancy and lactation section amended.
Updated on 15/02/2011 and displayed until 18/02/2011
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   07-Feb-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Information regarding patients with diabetes has been added to Section 4.4. Sections 4.6 & 4.8 have been expanded.
Updated on 14/12/2010 and displayed until 15/02/2011
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   07-Dec-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Change to shelf life from 24 to 36 months
Updated on 12/08/2010 and displayed until 14/12/2010
Reasons for adding or updating:
  • Change to section 4.6 - Pregnancy and Lactation
Date of revision of text on the SPC:   24-Jun-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Update to pregnancy and lactation information - epidemiological data.
Updated on 03/06/2010 and displayed until 12/08/2010
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
None provided

Active Ingredients/Generics

 
  venlafaxine hydrochloride